Fuente: Labiotech Lugar: Top Pharma Strategy Delve into what Merck has planned for the future of its pipeline as Keytruda's patent is getting closer to expiry.
The post Merck after Keytruda: what the pipeline looks like  appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.